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There is virtually no limit to the number of innovations being developed, tested and piloted 16 
at any one time to improve the quality and safety of care. The perennial problem is 17 
spreading innovations that are proven to be effective on a smaller scale or under controlled 18 
conditions. Much of the literature on spread refers to the important role played by external 19 
agencies in supporting the spread of innovations. External agencies can provide additional 20 
capacity and capabilities to adopter organisations, such as technical expertise, resources, 21 
and tools to assist with operational issues. In England, the NHS established 15 Academic 22 
Health Science Networks (AHSNs) to help accelerate the spread and adoption on 23 
innovation in healthcare. However, formal clinical-academic networks (such as AHSNs) of 24 
themselves will not deliver positive, tangible outcomes on the ground (i.e. evidence-based 25 
innovations embedded at scale across a system). This begs the question of how do AHSNs 26 
practically go about achieving this change successfully? We provide an AHSN's perspective 27 
on how we conceptualise and undertake our work in leading implementation of innovation 28 
at scale.  29 
 30 
Our approach is a collaborative process of widening understanding of the innovation and its 31 
implementation. At its core, the implementation and spread of innovation into practice is a 32 
collective social process. Healthcare comprises complex adaptive systems, where contexts 33 
need to be negotiated for implementation to be successful. As AHSNs, we aim to lead this 34 
negotiation through facilitating knowledge exchange and production across the system to 35 
mobilise the resources and collective action necessary for achieving spread. 36 
 37 
Introduction 38 
During 2013-2014, NHS England established 15 Academic Health Science Networks 39 
(AHSNs) to help accelerate the spread and adoption on innovation in healthcare. The role 40 
of AHSNs is to deliver a step-change in the way the NHS and social care identify, develop 41 
and adopt existing evidence-based innovations at scale. It is left to each of the AHSNs to 42 
determine how this is best achieved locally. However, formal clinical-academic networks 43 
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(such as AHSNs) of themselves will not deliver positive, tangible outcomes on the ground 44 
(i.e. evidence-based innovations embedded at scale across a system) [1,2]. This begs the 45 
question of how do AHSNs practically go about achieving this change successfully? We 46 
provide an AHSN's perspective on how we conceptualise the spread and adoption of 47 
innovation and give a case study to illustrate how we undertake our work in practice to lead 48 
scale-up across systems. This draws together perspectives from individuals in senior 49 
leaderships roles involved in the AHSN’s work from across clinical, managerial, and 50 
academic domains (e.g. medical/clinical Directors, a programme director, and senior 51 
academics). 52 
 53 
Historically, the research and innovation ‘pipeline’ has been geared towards a push model 54 
and consequently we see virtually no limit to the number of innovations being developed, 55 
tested and piloted at any one time. More recently, we are seeing a shift towards focusing 56 
on articulating needs more clearly and identifying (or developing) innovations that 57 
appropriately address these needs [3,4]. However, the perennial problem remains to how 58 
innovations can be implemented at scale to delivery intended benefits effectively [5].  59 
 60 
Much of the literature on spread refers to the important role played by external agencies in 61 
supporting the spread of innovations [6,7]. External agencies can provide additional 62 
capacity and capabilities to adopter organisations, such as technical expertise, resources, 63 
and tools to assist with operational issues [6,8]. Spread is also supported by continuous 64 
relationship building and partnership development activities [9]. Therefore, part of the way 65 
organisations can work most effectively to support the spread of innovations is by 66 




Conceptualising spread and adoption: An AHSN perspective 69 
Our experience as the AHSN for south London (or Health Innovation Network) resonates 70 
with the literature that there is no one “right way” to implement innovations at scale [5], 71 
and that spread and adoption is a non-linear, iterative, participatory, and resource intensive 72 
process  [5,9,12]. At its core spread is a process about building capacity and capabilities at 73 
multiple levels: individuals, organisations, and systems [5,8,13]. For spread to be effective it 74 
needs to be a planned, resourced, and managed approach, where consideration is given to 75 
developing the infrastructure required to support the individuals, organisations, and 76 
systems involved in the process [6,9]. 77 
 78 
Whilst spread efforts are a planned process underpinned by sound project and programme 79 
management, there also has to be a large amount of pragmatism to ‘make it happen’ . Our 80 
approach is underpinned by an ethos of working with the willing and remaining open to 81 
unforeseen opportunities. The need for flexibility is necessary to be able to respond to the 82 
turbulence and continuous change within the wider system [14]. Complexity theory 83 
recognises the limits of using formally planned approaches in complex adaptive systems, 84 
which have a countless array of parts and interdependencies that lead to unforeseen 85 
outcomes [1,15,16]. It accepts that local contextual factors are difficult to influence as they 86 
are emergent, dynamic and self-organising [1,15–17]. As a consequence, for interventions 87 
to spread we need to understand local variation and focus on adapting interventions to 88 
integrate into individual practice settings, rather than hold a uncompromising pre-89 




At its core, the implementation and spread of innovation into practice is a collaborative, 92 
collective social process [18,19]. The implementation of evidence into practice has typically 93 
been approached as a problem of knowledge transfer where the issue lies in the 94 
dissemination of knowledge from research to practice [20]. However, this framing ignores 95 
that practitioners create their own knowledge through their own experiences. It may be 96 
more helpful to re-frame it as a problem of knowledge production. All parties have partial 97 
and different knowledge; therefore, exchange and interaction by all parties is needed to 98 
create meaningful and actionable knowledge that is context and purpose specific [20]. This 99 
relies on shifting from a narrow concept of knowledge to include informal and tacit 100 
knowledge [21,22]. Kitson and colleagues suggest we move away from the idea of a ‘gap’, 101 
where users (as passive and peripheral recipients) and producers of knowledge or 102 
innovation engaged in push-pull activities, to a ‘space’ or ‘synapse of interaction and 103 
connectivity’ [1]. 104 
 105 
Using this conceptualisation, as an AHSN we work to draw on our own and providers’ 106 
practical experience of implementing innovation and combined this with formal evidence 107 
(e.g. research and evaluation), to reconstruct and evolve knowledge about the intervention 108 
and how to implement it across multiple contexts to achieve scale-up [18]. Our approach is 109 
to understand and drive the adaptive work needed to implement innovations successfully in 110 
different contexts, in order to support spread [17]. This largely focuses on ways to test 111 
spread by exploring and evaluating elements relating to where the intervention is delivered, 112 
who delivers it, to whom it is targeted, and how best to share this knowledge with 113 




Perhaps the best analogy to illustrate our work is gardening. The role of AHSNs is like 116 
expert gardeners or cultivators in a complex landscape. A need is identified that every 117 
patient in the country should have ready access to a new variety of tomato. There is a vision 118 
of this new crop being grown in every place in the land, but unfortunately there are very 119 
few vacant fields and the soil is in various levels of readiness or appropriateness to grow this 120 
particular variety of tomato. So AHSNs are asked to support. We know the land. We help 121 
prepare the ground. We make sure we understand the plant and also what the plant is due 122 
to provide, and whether there are other varieties that might be more appropriate for 123 
certain conditions. 124 
 125 
The approach to our groundwork is founded on the insights of clinical academics in 126 
implementation science. Our theory of change - the reasoning behind why we think our 127 
chosen approach is going to get us from A to B - depends on the unique circumstances 128 
present. The nature of spread and adoption work varies based on the specific innovation, 129 
barriers, enablers, and knowledge in the system. Thus, we do not use the same approach all 130 
the time or everywhere.  131 
 132 
Being part of a network of AHSNs, which have grown up with a variety of approaches, is a 133 
strength and something the ASHN network capitalises on. We are skilled in collaborative 134 
working; expert in building trust amongst people across different organisations and parts of 135 
the system. It is important that our organisation does not performance manage our 136 
members and we make it clear that we use data and information to motivate change and 137 
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bring insight rather than judge – whilst at times harnessing healthy competition between 138 
organisations who are then enabled by us to learn from one another.  139 
 140 
Spread and adoption in practice: An AHSN case study 141 
We support the spread and adoption of a wide range of innovations across a diverse 142 
number of settings: service-level interventions, digital platform for referrals, patient safety 143 
devices, and new diagnostic tests that change care pathways. The AHSNs also coordinate 144 
to support the scale-up of a set of national programmes (e.g. PReCePT - Preventing 145 
cerebral palsy in preterm babies; PINCER - Preventing prescribing errors in primary care; 146 
Serenity Integrated Mentoring – Supporting people with complex behavioural disorders 147 
who place high demands on emergency services and mental health teams). We will use one 148 
of these national programmes, ESCAPE-pain, as a case study to illustrate how AHSNs work 149 
in practice to achieve scale-up. 150 
The problem and the intervention: Osteoarthritis and the ESCAPE-pain programme 151 
There are approximately 8.75 million people in the UK living with osteoarthritis (OA) and 152 
this is projected to increase to 17 million by 2030 [23,24]. OA is a major cause of disability 153 
with a large socio-economic burden [25]. Despite NICE guidance [26] and proven 154 
interventions (such ESCAPE-pain), the management of OA remains sub-optimal because 155 
the evidence-base is not being implemented into practice [27,28]. ESCAPE-pain promotes 156 
self-management to improve quality of life and function [29–31]. The programme is 157 
delivered over six weeks via two weekly group sessions that last 45-60 minutes (with 15-20 158 
minutes of structured education and 30-45 minutes of individualised exercise). ESCAPE-159 
pain was shown to be  clinical and cost-effective through a large cluster randomised 160 
controlled trial and economic evaluation [29,30,32]. 161 
8 
 
AHSN involvement in spread 162 
In 2014, ESCAPE-pain was selected by the AHSN for south London (Health Innovation 163 
Network) as a priority for local scale-up. In April 2018, it became a national programme for 164 
scale-up supported by England’s 15 AHSNs for a 2-year period. Scale-up was coordinated 165 
by a national programme manager and locally dedicated resource (e.g. project manager, 166 
clinical champion) within each AHSN. 167 
Scale of spread achieved 168 
Following the AHSN Network national programme, ESCAPE-pain is now being delivered in 169 
260 sites with over 16,000 people with hip and knee OA completing the programme. This is 170 
a 4-fold increase in the number of sites and 3-fold increase in the number of participants 171 
compared to the start of the national programme in April 2018. The growth in sites during 172 
2018-2020 has been accompanied by a substantial expansion in geographical spread 173 
beyond London and South East England to include sites across all regions in England. This 174 
spread has been accompanied by an expansion in the models of delivery for ESCAPE-pain 175 
across an increasing range of settings (NHS and non-clinical community), providers (NHS, 176 
community leisure, local authority) and practitioners (physiotherapists, therapy assistants 177 
and fitness professionals) i.e. 53.5% of sites delivering the programme are non-clinical, 178 
community settings. Critically, monitoring of clinical outcomes demonstrates that ESCAPE-179 
pain continues to be clinically effective in ‘real world’ settings at levels comparable to the 180 
original RCT [33]. 181 
Coordinating the AHSN Network’s national programme for ESCAPE-pain 182 
The approach to coordinating the AHSN national programme for ESCAPE-pain has been 183 
underpinned by developing a cohesive partnership between AHSNs via peer support and 184 
knowledge sharing. The ESCAPE-pain core team based at the south London AHSN used a 185 
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range of approaches (e.g. regular webinars, face-to-face learning network meetings, 186 
FutureNHS collaborative online platform, annual review and planning meetings) to allow 187 
existing knowledge about spreading ESCAPE-pain to be shared, and to capture and 188 
exchange learning that emerged from the AHSN Network during the national programme 189 
(e.g. local contextual issues, strategies for local spread). Collectively, the AHSNs used this 190 
learning to develop a suite of resources to support local spread efforts (e.g. resources for 191 
commissioners with cost modelling, an implementation toolkit for providers, patient case 192 
studies, and marketing materials). 193 
 194 
In addition, the AHSNs developed a coordinated national monitoring programme to 195 
evaluate the scale and impact of spread (e.g. collecting data on the number of sites, 196 
location of sites, type of provider and site, number of cohorts and participants, and pre/post 197 
clinical outcomes). This has required significant investment in developing and maintaining 198 
monitoring and evaluation activities and infrastructure. 199 
AHSNs’ approaches to implementing and scaling-up ESCAPE-pain 200 
What we know from the literature that implementation strategies need to be chosen and 201 
tailored to accommodate the characteristics of the intervention, provider (or adopter), the 202 
team resourced to support implementation, and the wider system (or environment) [34–203 
36]. Key strategies used by AHSNs to implement ESCAPE-pain successfully were: 204 
• Developing stakeholder inter-relationships – Identifying and supporting local 205 
champions and early adopters, building local partnerships and consensus for 206 
ESCAPE-pain (i.e. identifying and agreeing the need and fostering a commitment 207 
and urgency to implement), and working with partners from across the system (e.g. 208 
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providers and commissioners from the NHS, local authority, and leisure and 209 
community sector) 210 
• Training and education – Developing and rolling out a mandatory 1-day training 211 
course on how to deliver and implement the programme, developing a suite of 212 
tailored and packaged resources about the evidence, delivery, and implementation 213 
of ESCAPE-pain. This involved developing a national network of trainers (largely 214 
drawn from local champions and the national team). 215 
• Using financial measures – Funding and contracting for ESCAPE-pain, for example 216 
embedded it within tenders, payment for delivering the programme, and providing 217 
free training. 218 
• Providing interactive assistance – Local AHSNs and the national team providing on-219 
going technical assistance to partners to support implementation. This included 220 
providing information and support around decision-making to adopt (e.g. business 221 
case templates, attending key meetings), resources and advice on implementation 222 
and delivery (e.g. implementation toolkit, site visits), and helping to problem-solve 223 
any issues impeding implementation. 224 
• Using evaluation and iterative strategies – a key approach used by AHSN has been 225 
to test and refine different ways of implementing ESCAPE-pain, to identify and 226 
share key barriers and facilitators, and learn about what works across a variety of 227 
settings and delivery models (e.g. exercise on referrals schemes, NHS-leisure 228 
provider partnerships). The on-going monitoring of ESCAPE-pain has facilitated 229 
scale-up by providing evidence to key decision-makers about its clinical and cost 230 




AHSNs’ choice of strategies was determined by a range of factors, such as the 233 
characteristics of providers (e.g. NHS, non-NHS community), the resources allocated within 234 
the AHSN to support work on ESCAPE-pain, and the wider system (e.g. extent of 235 
(dis)engagement by commissioner and key strategic decision-makers). Determining and 236 
deploying appropriate strategies required AHSNs to (1) be clear about their offer to local 237 
systems, including the level of resource available to support local implementation efforts; 238 
(2) clarify the scope of focus to their work on ESCAPE-pain i.e. targeting specific part of the 239 
system (e.g. only NHS providers) versus casting the net more widely; and (3) recognise the 240 
need for a multifaceted approach that engages directly with providers, as well as at 241 
operating at a system level (e.g. commissioners, interorganisational partnership). 242 
 243 
It is important to note that ESCAPE-pain has not been successful spread in all locations, 244 
where key barriers have been intractable and/or too many in number (i.e. a ‘perform storm’ 245 
of barriers). The factors most consistently encountered by AHSNs that impede the local 246 
scale-up of ESCAPE-pain were: (1) Current (predominant) funding models that are activity-247 
based and prioritise in-year cost savings within commissioners’ budgets. These models do 248 
not readily support the implementation of new interventions (such as ESCAPE-pain), which 249 
require greater upfront investment compared to incumbent interventions and may realise 250 
benefits in the long-term and across health and social care systems; (2) Attitudes towards 251 
evidence and evidence-based practice, particularly amongst senior managers and senior 252 
clinicians. Despite existing local alternative programmes having limited (or no) evidence of 253 
clinical and cost effectiveness, appetite for change could be low resulting in an 254 





The idea of the movement of research and innovation into practice as a pipeline is a poor 258 
conceptualisation of what happens in practice; the reality is a much messier and non-linear 259 
process. Our experience of the spread and adoption is that of a collective process 260 
underpinned by a process of exchanging knowledge (both formal and tactic) across 261 
systems. This process aims to build consensus and understanding about needs, viable 262 
solutions (or innovations) and their implementation. The spread of innovation is also about 263 
trying to understand local variation, but contextual factors are difficult to influence as they 264 
are dynamic and self-organising driven by the interactions and relationships between the 265 
components of the system. This makes it difficult to have a universal ‘blueprint’ for our 266 
work. In practice, our approach is to use strategies that deliberately support collaboration, 267 
flexibility, and partnership. By actively facilitating greater connectivity we can support 268 
systems to negotiate and mobilise the resources (e.g. knowledge, financial, relational) 269 
needed to spread and adopt innovation successfully. 270 
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